Ben Schryver - Barry Callebaut Chief Officer
| BARN Stock | CHF 1,334 12.00 0.89% |
Insider
Ben Schryver is Chief Officer of Barry Callebaut AG
| Age | 49 |
| Phone | 41 43 204 04 04 |
| Web | https://www.barry-callebaut.com |
Barry Callebaut Management Efficiency
The company has return on total asset (ROA) of 0.054 % which means that it generated a profit of $0.054 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of 0.1292 %, meaning that it generated $0.1292 on every $100 dollars invested by stockholders. Barry Callebaut's management efficiency ratios could be used to measure how well Barry Callebaut manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Giulio Evangelisti | COSMO Pharmaceuticals SA | 53 | |
| Lutz Wevelsiep | Basilea Pharmaceutica AG | N/A | |
| Astrid Schafer | Evolva Holding SA | 50 | |
| Ravi Anand | Newron Pharmaceuticals SpA | 66 | |
| Hazel Winchester | COSMO Pharmaceuticals SA | 52 | |
| Marc Schrader | Santhera Pharmaceuticals Holdin | N/A | |
| Stefan Weber | Newron Pharmaceuticals SpA | 58 | |
| Christian Wichert | Evolva Holding SA | N/A | |
| Dietrich Stber | Basilea Pharmaceutica AG | N/A | |
| Adesh Kaul | Basilea Pharmaceutica AG | 49 | |
| Damian Heller | Basilea Pharmaceutica AG | 57 | |
| FCMA CGMA | Santhera Pharmaceuticals Holdin | 60 | |
| Anne Vos | Evolva Holding SA | 59 | |
| Eva Kalias | Santhera Pharmaceuticals Holdin | N/A | |
| Shabir MD | Santhera Pharmaceuticals Holdin | N/A | |
| Laurenz Kellenberger | Basilea Pharmaceutica AG | 56 | |
| Sarah HolmesKlotz | Santhera Pharmaceuticals Holdin | N/A | |
| Davide Malavasi | COSMO Pharmaceuticals SA | 50 | |
| Oliver MBA | Evolva Holding SA | 54 | |
| Marc MD | Basilea Pharmaceutica AG | 59 | |
| Luigi Longo | COSMO Pharmaceuticals SA | 44 | |
Management Performance
| Return On Equity | 0.13 | |||
| Return On Asset | 0.054 |
Barry Callebaut AG Leadership Team
Elected by the shareholders, the Barry Callebaut's board of directors comprises two types of representatives: Barry Callebaut inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Barry. The board's role is to monitor Barry Callebaut's management team and ensure that shareholders' interests are well served. Barry Callebaut's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Barry Callebaut's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Olivier Delaunay, Chief Officer | ||
| Claudia Pedretti, Head Relations | ||
| Peter Boone, CEO Officer | ||
| Masha VisMertens, Chief Officer | ||
| Steven Vandamme, Chief Officer | ||
| Simone dEpinay, Head Fin | ||
| Ben Schryver, Chief Officer | ||
| Steven Retzlaff, Pres Cocoa | ||
| Frank Keidel, Head Relations | ||
| Erich Steinegger, Head Management |
Barry Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Barry Callebaut a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.13 | |||
| Return On Asset | 0.054 | |||
| Profit Margin | 0.04 % | |||
| Operating Margin | 0.08 % | |||
| Current Valuation | 11.25 B | |||
| Shares Outstanding | 5.48 M | |||
| Shares Owned By Insiders | 35.69 % | |||
| Shares Owned By Institutions | 32.50 % | |||
| Price To Earning | 37.07 X | |||
| Price To Book | 3.47 X |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Barry Stock Analysis
When running Barry Callebaut's price analysis, check to measure Barry Callebaut's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Barry Callebaut is operating at the current time. Most of Barry Callebaut's value examination focuses on studying past and present price action to predict the probability of Barry Callebaut's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Barry Callebaut's price. Additionally, you may evaluate how the addition of Barry Callebaut to your portfolios can decrease your overall portfolio volatility.